Genpharmasec Ltd — Updates, 21-05-2025: Company Update

Genpharmasec Limited has confirmed there is no deviation or variation in the use of proceeds from its Rights Issue totaling Rs. 4845.05 lakh. Funds have been utilized as intended: Rs. 1443.58 lakh for acquiring equity shares to make Derren Healthcare Private Limited a subsidiary, Rs. 286 lakh toward repayment of borrowings, Rs. 1638.86 lakh for working capital, Rs. 1019.80 lakh for general corporate purposes, and Rs. 25 lakh for issue expenses. This aligns fully with the original objectives, ensuring transparency and disciplined fund deployment for shareholders.